Abstract:Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), remains a global health burden. While Mtb is primarily a respiratory pathogen, it can spread to other organs, including the brain and meninges, causing TB meningitis (TBM). However, little is known about the immunological mechanisms that leads to differential disease across organs. Attention has focused on differences in T cell responses in the control of Mtb in the lungs, but emerging data point to a role for antibodies, as both biomarkers of disease control and as antimicrobial molecules. Given an increasing appreciation for compartmentalized antibody responses across the blood brain barrier, here we characterized the antibody profiles across the blood and brain compartments during TBM, and determined whether Mtb-specific humoral immune responses differed between Mtb infection of the lung (pulmonary TB) and TBM. Using a high throughput systems serology approach, we deeply profiled the antibody responses against 10 different Mtb antigens, including lipoarabinomannan (LAM) and purified protein derivative (PPD), in HIV-negative adults with pulmonary TB (n=10) vs TBM (n=60). Antibody studies included analysis of immunoglobulin isotypes (IgG, IgM, IgA) and subclass levels (IgG1-4), the capacity of Mtb-specific antibodies to bind to Fc receptors or C1q, and to activate innate immune effectors functions (complement and NK cells activation, monocyte or neutrophil phagocytosis). Machine learning methods were applied to characterize serum and CSF responses in TBM, identify prognostic factors associated with disease severity, and define the key antibody features that distinguish TBM from pulmonary TB. In individuals with TBM, we identified CSF-specific antibody profiles that marked a unique and compartmentalized humoral response against Mtb, characterized by an enrichment of Mtb-specific antibodies able to robustly activate complement and drive phagocytosis by monocytes and neutrophils, all of which were associated with milder TBM severity at presentation. Moreover, individuals with TBM exhibited Mtb-specific antibodies in the serum with an increased capacity to activate phagocytosis by monocytes, compared to individuals with pulmonary TB, despite having lower IgG titers and Fcγ receptors (FcγR)-binding capacity. Collectively, these data point to functionally divergent humoral responses depending on the site of infection (i.e. lungs vs brain), and demonstrate a highly compartmentalized Mtb-specific antibody response within the CSF during TBM. Moreover, our results suggest that phagocytosis- and complement-mediating antibodies may promote attenuated neuropathology and milder TBM disease.

Splenic marginal zone B cells restrict Mycobacterium tuberculosis infection by shaping the cytokine pattern and cell-mediated immunity

CD11b(+) Dendritic Cell-Mediated Anti-Mycobacterium Tuberculosis Th1 Activation is Counterregulated by CD103(+) Dendritic Cells Via IL-10

Airway Macrophages Mediate Mucosal Vaccine-Induced Trained Innate Immunity against Mycobacterium tuberculosis in Early Stages of Infection.

Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control

B cell heterogeneity in human tuberculosis highlights compartment-specific phenotype and functional roles

Ablation of B cell-derived IL-10 increases tuberculosis resistance

Cd4(+)Cd25(+)Foxp3(+) Regulatory T Cells Suppress Mycobacterium Tuberculosis Immunity in Patients with Active Disease

Mycobacterial Lipoprotein Z Triggers Efficient Innate and Adaptive Immunity for Protection Against Mycobacterium Tuberculosis Infection

Antibody-Fab and -Fc features promote Mycobacterium tuberculosis restriction.

Antibodies as key mediators of protection against Mycobacterium tuberculosis

Mycobacterium Tuberculosis Culture Filtrate Protein 10-Specific Effector/Memory Cd4(+) And Cd8(+) T Cells In Tubercular Pleural Fluid, With Biased Usage Of T Cell Receptor V Beta Chains

Antigen specificity shapes antibody functions in tuberculosis.

B cells in perivascular and peribronchiolar granuloma-associated lymphoid tissue and B-cell signatures identify asymptomatic Mycobacterium tuberculosis lung infection in Diversity Outbred mice

Stromal structure remodeling by B lymphocytes limits T cell activation in lymph nodes of Mycobacterium tuberculosis-infected mice

Distinctive antibody responses to Mycobacterium tuberculosis in pulmonary and brain infection

Single‐Cell Sequencing Reveals Functional Alterations in Tuberculosis

The role of lymphocyte subsets in preventing tuberculosis following intravenous vaccination with BCG

Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis.

B cell infiltration is associated with the increased IL-17 and IL-22 expression in the lungs of patients with tuberculosis

T cell receptor repertoire deciphers anti-tuberculosis immunity

Specific CD4 + T cell phenotypes associate with bacterial control in people who 'resist' infection with Mycobacterium tuberculosis